Upgrade to SI Premium - Free Trial

Ascendiant Capital Downgrades PhotoMedex (PHMD) to Buy

March 14, 2014 7:16 AM
Ascendiant Capital downgraded PhotoMedex (NASDAQ: PHMD) from Strong Buy to Buy with a price target of $18.00 (from $20.00).

For an analyst ratings summary and ratings history on PhotoMedex click here. For more ratings news on PhotoMedex click here.

Shares of PhotoMedex closed at $16.45 yesterday, with a 52 week range of $10.51-$17.05.

Categories

Analyst PT Change Downgrades

Next Articles